{"transactions":[{"id":710405,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-13T20:32:14.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of July 9, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":60000,"derivative":{"exercise_price":1.13,"expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001867426-26-000004","document":"wk-form4_1783974731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000186742626000004/wk-form4_1783974731.xml","form_type":"4"}},{"id":728586,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:42:07.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":3127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":3127,"derivative":{"exercise_price":162.99,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001610717-26-000281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000281/form4.xml","form_type":"4"}},{"id":728585,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-23T21:42:07.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,191 Restricted Stock Units."}],"balance_after":26215,"source":{"system":"sec-edgar","filing":"0001610717-26-000281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000281/form4.xml","form_type":"4"}},{"id":1098957,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T20:24:54.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":11574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":11574,"derivative":{"exercise_price":37.48,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":11574},"source":{"system":"sec-edgar","filing":"0001610717-25-000269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000269/form4.xml","form_type":"4"}},{"id":1098956,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-30T20:24:54.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":3142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,142 Restricted Stock Units."}],"balance_after":25024,"source":{"system":"sec-edgar","filing":"0001610717-25-000269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000269/form4.xml","form_type":"4"}},{"id":1466979,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T21:08:29.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":15955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date."}],"balance_after":15955,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":15955},"source":{"system":"sec-edgar","filing":"0001610717-24-000378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000378/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1466978,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-28T21:08:29.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,851 restricted stock units (\"RSUs\")."}],"balance_after":21882,"source":{"system":"sec-edgar","filing":"0001610717-24-000378","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000378/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1470309,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T20:20:27.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":16700,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001610717-24-000357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000357/form4.xml","form_type":"4"}},{"id":1470308,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-24T20:20:27.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,403 Restricted Stock Units."}],"balance_after":22434,"source":{"system":"sec-edgar","filing":"0001610717-24-000357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000357/form4.xml","form_type":"4"}},{"id":1471093,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T19:49:14.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.569,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-077008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000095017024077008/ownership.xml","form_type":"4"}},{"id":1858261,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:17:22.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":24.84,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001610717-23-000136","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000136/form4.xml","form_type":"4"}},{"id":1858260,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-12T20:17:22.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 8,817 Restricted Stock Units."}],"balance_after":17634,"source":{"system":"sec-edgar","filing":"0001610717-23-000136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000136/form4.xml","form_type":"4"}},{"id":1861102,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:13:04.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.5,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-036004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123036004/doc4.xml","form_type":"4"}},{"id":2226601,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:06:03.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 16, 2022 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001567619-22-013112","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761922013112/doc1.xml","form_type":"4"}},{"id":2226600,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T21:06:03.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,626 Restricted Stock Units."}],"balance_after":12434,"source":{"system":"sec-edgar","filing":"0001567619-22-013112","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761922013112/doc1.xml","form_type":"4"}},{"id":2236529,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T16:54:20.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.24,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-035954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919122035954/doc4.xml","form_type":"4"}},{"id":2600873,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-17T18:11:37.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36) of the shares subject to the option shall vest monthly beginning on the one month anniversary of August 16, 2021 (the \"Vesting Commencement Date\"), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date."}],"balance_after":80000,"derivative":{"exercise_price":9.19,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-21-052010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919121052010/doc4.xml","form_type":"4"}},{"id":2655493,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T21:18:13.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":25318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 22, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":25318,"derivative":{"exercise_price":32.93,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":25318},"source":{"system":"sec-edgar","filing":"0001567619-21-012592","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761921012592/doc1.xml","form_type":"4"}},{"id":2655492,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":30726,"kind":"person","name":"Borellini Flavia","position":1,"cik":"0001867426","reported_name":"Borellini Flavia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T21:18:13.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":7234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,234 Restricted Stock Units."}],"balance_after":7234,"source":{"system":"sec-edgar","filing":"0001567619-21-012592","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761921012592/doc1.xml","form_type":"4"}}]}